Improved diaphragmatic impairment in nusinersen-treated SMA

German researchers studied diaphragmatic function in 28 adults with SMA, before and after treatment with nusinersen (Spinraza®) :

  • 10 with SMA type II and 14 with type III,
  • diaphragm thickening and stroke were assessed by ultrasound and correlated with parameters from other respiratory function tests,
  • both parameters improved after treatment.

The authors of this work emphasize that the diaphragm, classically preserved in SMA, can be affected in 20-30% of adult patients, and that its function can improve with treatment.

 

Impaired diaphragmatic motility in treatment-naive adult patients with spinal muscular atrophy improved during nusinersen treatment. Freigang M, Langner S, Hermann A, Günther R. Muscle Nerve. 2023 Sept.